APA (7th ed.) Citation

Filippi, M., Grimaldi, L., Conte, A., Totaro, R., Valente, M. R., Malucchi, S., . . . Ferrazzano, G. (2024). Intravenous or subcutaneous natalizumab in patients with relapsing–remitting multiple sclerosis: Investigation on efficiency and savings—the EASIER study. Journal of Neurology, 271(1), 340. https://doi.org/10.1007/s00415-023-11955-0

Chicago Style (17th ed.) Citation

Filippi, Massimo, et al. "Intravenous or Subcutaneous Natalizumab in Patients with Relapsing–remitting Multiple Sclerosis: Investigation on Efficiency and Savings—the EASIER Study." Journal of Neurology 271, no. 1 (2024): 340. https://doi.org/10.1007/s00415-023-11955-0.

MLA (9th ed.) Citation

Filippi, Massimo, et al. "Intravenous or Subcutaneous Natalizumab in Patients with Relapsing–remitting Multiple Sclerosis: Investigation on Efficiency and Savings—the EASIER Study." Journal of Neurology, vol. 271, no. 1, 2024, p. 340, https://doi.org/10.1007/s00415-023-11955-0.